- Home
- BLDE vs RCKT Comparison
BLDE vs RCKT Comparison
Compare BLDE & RCKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BLDE
- RCKT
- Stock Information
- Founded
- BLDE 2014
- RCKT 1999
- Country
- BLDE United States
- RCKT United States
- Employees
- BLDE N/A
- RCKT N/A
- Industry
- BLDE Aerospace
- RCKT Biotechnology: Pharmaceutical Preparations
- Sector
- BLDE Consumer Discretionary
- RCKT Health Care
- Exchange
- BLDE Nasdaq
- RCKT Nasdaq
- Market Cap
- BLDE 285.2M
- RCKT 264.0M
- IPO Year
- BLDE N/A
- RCKT N/A
- Fundamental
- Price
- BLDE $4.13
- RCKT $2.81
- Analyst Decision
- BLDE Strong Buy
- RCKT Buy
- Analyst Count
- BLDE 2
- RCKT 13
- Target Price
- BLDE $6.25
- RCKT $18.50
- AVG Volume (30 Days)
- BLDE 656.1K
- RCKT 3.6M
- Earning Date
- BLDE 08-06-2025
- RCKT 08-04-2025
- Dividend Yield
- BLDE N/A
- RCKT N/A
- EPS Growth
- BLDE N/A
- RCKT N/A
- EPS
- BLDE N/A
- RCKT N/A
- Revenue
- BLDE $251,485,000.00
- RCKT N/A
- Revenue This Year
- BLDE $5.58
- RCKT N/A
- Revenue Next Year
- BLDE $8.56
- RCKT N/A
- P/E Ratio
- BLDE N/A
- RCKT N/A
- Revenue Growth
- BLDE 8.67
- RCKT N/A
- 52 Week Low
- BLDE $2.35
- RCKT $2.19
- 52 Week High
- BLDE $5.17
- RCKT $26.98
- Technical
- Relative Strength Index (RSI)
- BLDE 57.24
- RCKT 41.85
- Support Level
- BLDE $4.02
- RCKT $2.76
- Resistance Level
- BLDE $4.32
- RCKT $3.24
- Average True Range (ATR)
- BLDE 0.19
- RCKT 0.19
- MACD
- BLDE -0.01
- RCKT 0.13
- Stochastic Oscillator
- BLDE 69.60
- RCKT 49.10
About BLDE Blade Air Mobility Inc.
Blade Air Mobility Inc is a technology-powered air mobility platform that provides air transportation and logistics for hospitals and is a transporter of human organs for transplant, and for passengers, with helicopter and fixed-wing services predominantly in the Northeast United States, Southern Europe and Western Canada. The company's operating segments are; Passenger, and Medical. Majority of the revenue for the company is generated from its Medical segment which predominantly consists of transportation of human organs for transplant and the medical teams supporting these services. It also offers additional services including donor logistics coordination and support in evaluating potential donor organs. A substantial portion of the company's revenue is generated from the United States.
About RCKT Rocket Pharmaceuticals Inc.
Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. The Company has one reportable segment related to R&D and commercial readiness of its gene therapies.